On September 19, 2014, the Massachusetts Alzheimer's Disease Research Center (ADRC)
held a daylong scientific symposium to celebrate 30 years of research productivity. It was a …

This perspective updates the status of the “National Plan to Address Alzheimer's Disease”
and the recommendations of the NAPA Advisory Council's Sub-committee on Research …

This report outlines a goal‐directed scientific agenda for a national initiative to overcome the
Alzheimer's disease (AD) crisis. The statement, which reflects the collective views and …

Abstract The National Alzheimer's Coordinating Center (NACC) is responsible for
developing and maintaining a database of patient information collected from the 29 …

To understand the current thinking and future research directions in Alzheimer disease (AD),
it is essential to examine the breadth of research into AD. AD was identified as a distinct …

The public Alzheimer's disease (AD) research enterprise began in earnest in the mid-1970s
with the creation by Congress of the National Institute on Aging at the National Institutes of …

Alzheimer's Association received acceptance for inclusion in MEDLINE, the bibliographic
database of the US National Library of Medicine (NLM). Three years since the launch, this …

Alzheimer's disease (AD), is the most common form of dementia. There is no cure for the
disease, which worsens as it progresses, and eventually leads to death. The cause and …

During the first two decades of the life of this Journal (ADAD) much progress has been made
in our understanding of Alzheimer disease (AD). Advancing knowledge, however, has been …

On 26 January 2010, at an ordinary airport hotel in Phoenix, Arizona, an extraordinary
gathering unfolded. High-level representatives of 19 different pharma, biotech, and medical …